Prosecution Insights
Last updated: November 04, 2026
Application No. 18/936,019

DROPLET PROCESSING METHODS AND SYSTEMS

Non-Final OA §103
Filed
Nov 04, 2024
Priority
Aug 08, 2018 — GB 1812912.2 +2 more
Examiner
ABDI, AMARA
Art Unit
2668
Tech Center
2600 — Communications
Assignee
Sphere Fluidics Limited
OA Round
1 (Non-Final)
83%
Grant Probability
Favorable
1-2
OA Rounds
7m
Est. Remaining
76%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
703 granted / 846 resolved
+21.1% vs TC avg
Minimal -7% lift
Without
With
+-7.3%
Interview Lift
resolved cases with interview
Typical timeline
2y 7m
Avg Prosecution
26 currently pending
Career history
871
Total Applications
across all art units

Statute-Specific Performance

§101
11.0%
-29.0% vs TC avg
§103
64.2%
+24.2% vs TC avg
§102
9.8%
-30.2% vs TC avg
§112
9.6%
-30.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 846 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Objections Claim 16 is objected to because of the following informalities: -- claim 16, line 12, “to control the a microfluidics” should read “to control the microfluidics”. Appropriate correction is required. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 15, and 16 are rejected under 35 U.S.C. 103 as being unpatentable over Kim et al, (US-PGPUB 20190384963) in view of Hirata et al, (US-PGPUB 2018/0193559) Regarding claim 1, Kim et al discloses an instrument for microfluidic droplet-based processing of cells or other entities, the instrument comprising: a microfluidic droplet processing system, (154 in Fig. 1A, 200 in Fig. 1B) to process droplets of an emulsion, the droplets comprising cells or other entities, (see at least: Par. 0073, 0100, a master controller 154 comprising …. a motive module 162 for controlling movement and/or selection of micro-objects (not shown) and/or medium (e.g., droplets of medium) in the microfluidic circuit 120. Further, on Par. 0040, … biological micro-objects such as cells, implicit that the droplets comprising cells, [i.e., microfluidic droplet processing system, (154 in Fig. 1A) to process droplets of an emulsion, “implicit by controlling movement and/or selection of micro-objects (not shown) and/or medium (e.g., droplets of medium) in the microfluidic circuit 120 by the motive module 162”, the droplets comprising cells or other entities, “biological micro-objects represents the cells”]); a droplet sorting and/or dispensing system to dispense the processed droplets into one or more reservoirs, (see at least: Par. 0075, 0087, the media module 160 can control the media source 178 to input a selected fluidic medium 180 into the enclosure 102 (e.g., through an inlet port 107), [i.e., a droplet sorting and/or dispensing system, (178 in Fig. 1), to dispense the processed droplets into one or more reservoirs, “input a selected fluidic medium 180 into the enclosure 102”]); wherein the droplet processing system, (200 in Fig. 1B), comprises: an image capture device to capture a sequence of images of a droplet as it passes through a channel in the microfluidic droplet processing system, (see at least: Fig. 1a, and Par. 0073, 0068, 0077, an imaging module 164 for controlling an imaging device 194 (e.g., a camera, microscope, light source or any combination thereof) for capturing images (e.g., digital images) movement and/or of medium (e.g., droplets of medium) in the microfluidic circuit 120, [i.e., an image capture device, (164 in Fig. 1), to capture a sequence of images of a droplet as it passes through a channel in the microfluidic droplet processing system, “implicit by capturing images (e.g., digital images) movement”]); a convolutional neural network to process each image of the sequence of images to count a number of cells or other entities visible in each image the droplet, (see at least: Par. 0004, generating a plurality of pixel masks from the image for a corresponding plurality of micro-object characteristics including processing pixel data from the image using a machine learning algorithm, such as a convolutional neural network; and identifying micro-objects in the image from at least one pixel mask of the plurality, and obtaining a count of the identified micro-objects in the image. See also, Par. 0257, a system utilizing a CNN obtains a micro-object count, “cell count”, from an image input, [i.e., a convolutional neural network, “CNN” to process each image of the sequence of images, “processing each image input”, to count a number of cells or other entities visible in each image the droplet, “implicit by obtaining a micro-object count from an image input”]); and a processor, “microfluidic device 200”, configured to: determine an estimated number of cells or other entities in the droplet from the count of the number of cells or other entities visible in each image of the sequence of images of the droplet, (see at least: Par. 0257, the obtaining a micro-object count, from this analysis, technically enables determining an estimated number of cells or other entities in the droplet based on the micro-object count obtained from this analysis, [i.e., determining an estimated number of cells or other entities in the droplet, “implicitly obtaining estimated number of cells or other entities in the droplet based on the micro-object count obtained from this analysis]). Kim et al does not expressly disclose controlling the droplet sorting and/or dispensing system responsive to the estimated number of cells or other entities in the droplet. However, Hirata et al discloses controlling the droplet sorting and/or dispensing system responsive to the estimated number of cells or other entities in the droplet, (see at least: Par. 0003, an existing transfusion system that counts the number of the liquid droplets dripping from the lower end of a nozzle in a drip cylinder and controls a dripping rate of the liquid droplets in accordance with the counted number, [i.e., controlling a microfluidic process performed on the droplet, “implicit by controlling the dripping rate of the liquid droplets “, responsive to the estimated number of cells or other entities in the droplet, “in accordance with the counted number of the liquid droplets”]), (Hirata et al, Par. 0003). Kim et al and Hirata et al are combinable because they are both concerned with analyzing droplet images. Therefore, it would have been obvious to a person of ordinary skill in the art, to modify Kim et al, to count number of droplets, as though by Hirata et al, in order to control the dripping rate of the droplets, (Hirata, Par. 0003). Regarding claim 15, Kim discloses an instrument for microfluidic droplet-based processing of cells or other entities, the instrument comprising: a microfluidic droplet processing system, (154 in Fig. 1A, 200 in Fig. 1B), to process droplets of an emulsion, the droplets comprising cells or other entities, (see at least: Par. 0073, 0100, a master controller 154 comprising …. a motive module 162 for controlling movement and/or selection of micro-objects (not shown) and/or medium (e.g., droplets of medium) in the microfluidic circuit 120. Further, on Par. 0040, … biological micro-objects such as cells, implicit that the droplets comprising cells, [i.e., microfluidic droplet processing system, (154 in Fig. 1A) to process droplets of an emulsion, “implicit by controlling movement and/or selection of micro-objects (not shown) and/or medium (e.g., droplets of medium) in the microfluidic circuit 120 by the motive module 162”, the droplets comprising cells or other entities, “biological micro-objects represents the cells”]); a droplet sorting and/or dispensing system to dispense the processed droplets into one or more reservoirs, a droplet sorting and/or dispensing system to dispense the processed droplets into one or more reservoirs, (see at least: Par. 0075, 0087, the media module 160 can control the media source 178 to input a selected fluidic medium 180 into the enclosure 102 (e.g., through an inlet port 107), [i.e., a droplet sorting and/or dispensing system, (178 in Fig. 1), to dispense the processed droplets into one or more reservoirs, “input a selected fluidic medium 180 into the enclosure 102”]); wherein the droplet processing system, (200 in Fig. 1B), comprises: an optical signal capture device, (194 in Fig. 1), to capture a time sequence of optical signals from a droplet as it passes through a channel in the microfluidic droplet processing system, (see at least: Fig. 1a, and Par. 0073, 0068, 0077, an imaging module 164 for controlling an imaging device 194 (e.g., a camera, microscope, light source or any combination thereof) for capturing images (e.g., digital images) movement and/or of medium (e.g., droplets of medium) in the microfluidic circuit 120; and on Par. 0068, the imaging device 194 can also include a mechanism for directing stimulating radiation and/or light beams into the microfluidic circuit 120 and collecting radiation and/or light beams reflected or emitted from the microfluidic circuit 120 (or micro-objects contained therein, “i.e., imaging device 194 is implicitly an optical signal capture device, [i.e., an optical signal capture device, (194 in Fig. 1), to capture a time sequence of optical signals from a droplet as it passes through a channel in the microfluidic droplet processing system, “implicit by collecting radiation and/or light beams reflected or emitted from the microfluidic circuit 120, comprising the droplet, as implicitly it passe it passes through the microfluidic circuit 120”]); a set of one or more classifier neural networks to process the time sequence of optical signals to determine data characterizing one or more cells or entities in the droplet, (see at least: Par. 0257, a system utilizing a CNN obtains a micro-object count from an image input by annotating a plurality of pixels of the input image, each pixel annotation of the set representing a probability that a corresponding pixel in the image represents the corresponding micro-object characteristic, where the plurality of micro-object characteristics comprises at least three micro-object characteristics, including at least, a micro-object center, a micro-object edge, and a non-micro-object (or cell center, cell edge, and non-cell, [i.e., a set of one or more classifier neural networks, “CNN”, to process the time sequence of optical signals, “implicitly processing radiation and/or light beams reflected or emitted from micro-objects or cells acquired by microscopic imaging device”, to determine data characterizing one or more cells or entities in the droplet, “to obtain micro-object characteristics comprising at least three micro-object characteristics”]); and Kim does not expressly disclose a processor configured to control the droplet sorting and/or dispensing system responsive to the data characterizing the one or more cells or entities in the droplet. However, Hirata et al discloses controlling the droplet sorting and/or dispensing system responsive to the estimated number of cells or other entities in the droplet, (see at least: Par. 0003, an existing transfusion system that counts the number of the liquid droplets dripping from the lower end of a nozzle in a drip cylinder and controls a dripping rate of the liquid droplets in accordance with the counted number, [i.e., controlling a microfluidic process performed on the droplet, “implicit by controlling the dripping rate of the liquid droplets “, responsive to the estimated number of cells or other entities in the droplet, “in accordance with the counted number of the liquid droplets”]), (Hirata et al, Par. 0003). Kim and Hirata are combinable because they are both concerned with analyzing droplet images. Therefore, it would have been obvious to a person of ordinary skill in the art, to modify Kim et al, to count number of droplets, as though by Hirata et al, in order to control the dripping rate of the droplets, (Hirata, Par. 0003). Regarding claim 16, claim 16 recites substantially similar limitations as set forth in claim 1. As such, claim 16 is rejected for at least similar rational. Kim et al does not expressly disclose a processor configured to control the microfluidic process performed on the droplet responsive to the data characterizing the one or more cells or entities in the droplet” However, Hirata et al discloses controlling a microfluidic process performed on the droplet responsive to the data characterizing the one or more entities in the droplet, (see at least: Par. 0003, an existing transfusion system that counts the number of the liquid droplets dripping from the lower end of a nozzle in a drip cylinder and controls a dripping rate of the liquid droplets in accordance with the counted number, [i.e., implicitly controlling a microfluidic process performed on the droplet, “controlling the dripping rate of the liquid droplets “, responsive to the data characterizing the one or more entities in the droplet, “in accordance with the counted number of the liquid droplets”]), (Hirata et al, Par. 0003). Kim et al and Hirata et al are combinable because they are both concerned with analyzing droplet images. Therefore, it would have been obvious to a person of ordinary skill in the art, to modify Kim et al, to count number of droplets, as though by Hirata et al, in order to control the dripping rate of the droplets, (Hirata, Par. 0003). Claims 2, and 3 are rejected under 35 U.S.C. 103 as being unpatentable over Kim and Hirata, as applied to claim 1 above; and further in view of Wong et al, (US-PGPUB 20200072730) Regarding claim 2, the combination of Kim and Hirata as whole discloses the limitations of claim 1. Kim further discloses wherein the processor is further configured to: process each image of the sequence of images using the convolutional neural network to determine the count of the number of cells or other entities visible in each image of the sequence of images, (see at least: Par. 0004, … processing pixel data from the image using a machine learning algorithm, such as a convolutional neural network; and identifying micro-objects in the image from at least one pixel mask of the plurality, and obtaining a count of the identified micro-objects in the image. See also, Par. 0257, a system utilizing a CNN obtains a micro-object count, “cell count”, from an image input, and from Fig. 1a, and Par. 0073, 0068, 0077, … an imaging device 194 … for capturing images (e.g., digital images), “sequence of images”, [i.e., the processor, “controller”, is configured to process each image of the sequence of images using the convolutional neural network, “processing pixel data from the image using CNN”, to determine the count of the number of cells or other entities visible in each image of the sequence of images, “implicit by obtaining a micro-object count from an image input”]); The combination of Kim and Hirata as whole does not expressly disclose combining the count of the number of cells or other entities visible in each image of the droplet to determine the estimated number of cells or other entities in the droplet. However, Wong discloses combining the count of the number of cells or other entities visible in each image of the droplet to determine the estimated number of cells or other entities in the droplet, (see at least: Par. 0023, using controller for estimating the number of live cells (e.g. viable cells) as well as the number of dead cells, and identifying the total number of cells by combining the number of dead cells with the number of live cells; and on Par. 0042, the controller may employ any of a variety of classifiers and/or classification techniques to classify the objects in the focused image, comprising …. a convolutional neural network, [i.e., combining the count of the number of cells or other entities visible in each image of the droplet, “implicit by using controller to combine the number of dead cells with the number of live cells”, to determine the estimated number of cells or other entities in the droplet, “implicitly determining total number of cells based on combining the number of dead cells with the number of live cells”]). Kim, Hirata, and Wong are combinable because they are all concerned with analyzing images of sample. Therefore, it would have been obvious to a person of ordinary skill in the art, to modify combination of Kim and Hirata, to use the controller, as though by Wong, in order to estimate the total number of cells in the focused image, (Wong, Par. 0021). Regarding claim 3, the combination of Kim, Hirata, and Wong as whole discloses the limitations of claim 2. Wong further discloses wherein the processor is further configured to: process each image of the sequence of images using the convolutional neural network to classify each image of the droplet into one of a plurality of categories, (see at least: Par. 0023, classify the objects in the focused image as, for example, a live single cell, a live cell cluster, a dead cell, or debris; and on Par. 0042, the controller may employ any of a variety of classifiers and/or classification techniques to classify the objects in the focused image, comprising …. a convolutional neural network, [i.e., process each image of the sequence of images using the convolutional neural network, “implicitly processing one or more images using CNN”, to classify each image of the droplet into one of a plurality of categories, “classify the objects in the focused image ..into a live single cell, a live cell cluster, a dead cell, or debris”]), to determine the count of the number of cells or other entities visible in each image of the sequence of images, (see at least: Par. 0023, the total number of cells may be identified by combining the number of dead cells with the number of live cells). Allowable Subject Matter Claims 4-7, and 11-14 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. With respect to claim 4, the prior art of record, alone or in reasonable combination, does not teach or suggest, the following underlined limitation(s), (in consideration of the claim as a whole): “wherein the processor is further configured to: process each image of the sequence of images at a first resolution using the convolutional neural network, obtain a second higher resolution image of the cell/entity, process the second, higher resolution image of the cell or other entity to characterize the cell or other entity and/or an event associated with the cell or other entity, and output characterization data for the cell or other entity”. The relevant prior art of record, Kim et al, (US-PGPUB 20190384963) discloses an instrument for microfluidic droplet-based processing of cells or other entities, the instrument comprising: a microfluidic droplet processing system, (154 in Fig. 1A, 200 in Fig. 1B) to process droplets of an emulsion, the droplets comprising cells or other entities, (see at least: Par. 0073, 0100, a master controller 154 comprising …. a motive module 162 for controlling movement and/or selection of micro-objects (not shown) and/or medium (e.g., droplets of medium) in the microfluidic circuit 120. Further, on Par. 0040, … biological micro-objects such as cells, implicit that the droplets comprising cells, [i.e., microfluidic droplet processing system, (154 in Fig. 1A) to process droplets of an emulsion, “implicit by controlling movement and/or selection of micro-objects (not shown) and/or medium (e.g., droplets of medium) in the microfluidic circuit 120 by the motive module 162”, the droplets comprising cells or other entities, “biological micro-objects represents the cells”]); a droplet sorting and/or dispensing system to dispense the processed droplets into one or more reservoirs, (see at least: Par. 0075, 0087, the media module 160 can control the media source 178 to input a selected fluidic medium 180 into the enclosure 102 (e.g., through an inlet port 107), [i.e., a droplet sorting and/or dispensing system, (178 in Fig. 1), to dispense the processed droplets into one or more reservoirs, “input a selected fluidic medium 180 into the enclosure 102”]); wherein the droplet processing system, (200 in Fig. 1B), comprises: an image capture device to capture a sequence of images of a droplet as it passes through a channel in the microfluidic droplet processing system, (see at least: Fig. 1a, and Par. 0073, 0068, 0077, an imaging module 164 for controlling an imaging device 194 (e.g., a camera, microscope, light source or any combination thereof) for capturing images (e.g., digital images) movement and/or of medium (e.g., droplets of medium) in the microfluidic circuit 120, [i.e., an image capture device, (164 in Fig. 1), to capture a sequence of images of a droplet as it passes through a channel in the microfluidic droplet processing system, “implicit by capturing images (e.g., digital images) movement”]); a convolutional neural network to process each image of the sequence of images to count a number of cells or other entities visible in each image the droplet, (see at least: Par. 0004, generating a plurality of pixel masks from the image for a corresponding plurality of micro-object characteristics including processing pixel data from the image using a machine learning algorithm, such as a convolutional neural network; and identifying micro-objects in the image from at least one pixel mask of the plurality, and obtaining a count of the identified micro-objects in the image. See also, Par. 0257, a system utilizing a CNN obtains a micro-object count, “cell count”, from an image input, [i.e., a convolutional neural network, “CNN” to process each image of the sequence of images, “processing each image input”, to count a number of cells or other entities visible in each image the droplet, “implicit by obtaining a micro-object count from an image input”]); and a processor, “microfluidic device 200”, configured to: determine an estimated number of cells or other entities in the droplet from the count of the number of cells or other entities visible in each image of the sequence of images of the droplet, (see at least: Par. 0257, the obtaining a micro-object count, from this analysis, technically enables determining an estimated number of cells or other entities in the droplet based on the micro-object count obtained from this analysis, [i.e., determining an estimated number of cells or other entities in the droplet, “implicitly obtaining estimated number of cells or other entities in the droplet based on the micro-object count obtained from this analysis]). Kim further discloses the system will generally orient the input image as an array of pixel values, which the pixel values, depending on the image resolution and size, (Par. 0203), [i.e., implicitly processing each image at a first resolution based on using pixel values for the input image]. However, Kim fails to teach or suggest, either alone or in combination with the other cited references, obtaining a second higher resolution image of the cell/entity, processing the second, higher resolution image of the cell or other entity to characterize the cell or other entity and/or an event associated with the cell or other. A further prior art of record, Hirata et al, (US-PGPUB 2018/0193559) discloses controlling the droplet sorting and/or dispensing system responsive to the estimated number of cells or other entities in the droplet, (see at least: Par. 0003, an existing transfusion system that counts the number of the liquid droplets dripping from the lower end of a nozzle in a drip cylinder and controls a dripping rate of the liquid droplets in accordance with the counted number, [i.e., controlling a microfluidic process performed on the droplet, “implicit by controlling the dripping rate of the liquid droplets “, responsive to the estimated number of cells or other entities in the droplet, “in accordance with the counted number of the liquid droplets”]), but fails to teach or suggest, either alone or in combination with the other cited references, obtaining a second higher resolution image of the cell/entity, processing the second, higher resolution image of the cell or other entity to characterize the cell or other entity and/or an event associated with the cell or other. With respect to claim 5, the prior art of record, alone or in reasonable combination, does not teach or suggest, the following underlined limitation(s), (in consideration of the claim as a whole): “activate a cell/entity-associated event with a controlled timing upstream of a location of the image capture device such that a transient cell/entity-associated optical signal is produced at the location of the image capture device; and identify presence of the transient cell/entity-associated signal in one or more of the captured sequence of images”. The prior art of record, Kim et al, (US-PGPUB 20190384963), and Hirata et al, (US-PGPUB 2018/0193559), cited above with respect to claim 4, apply also to claim 5, but none, either alone or in combination, teach or suggest all the claimed limitations. A further prior art of record, Charlot et al, (US-PGPUB 20100289887) discloses the identifying a transient cell/entity- associated signal, (see at least: Par. 0009, an instrument for automatically measuring transient activity in cells uses image time sequences to identify transients in cells); fails to teach or suggest, either alone or in combination with the other cited references, activating a cell/entity-associated event with a controlled timing upstream of a location of capturing the sequence of images of the droplet such that a transient cell/entity-associated optical signal is produced at the location of capturing the sequence of images; the method further comprising using the or another convolutional neural network to identify presence of the transient cell/entity-associated signal in one or more of the captured sequence of images. Regarding claim 6, claim 6 is in condition for allowance, in view of its dependency on claim 5. With respect to claim 7, the prior art of record, alone or in reasonable combination, does not teach or suggest, the following underlined limitation(s), (in consideration of the claim as a whole): “wherein as the droplet passes through the channel in the microfluidic droplet processing system the number of cells or other entities visible in the droplet changes, and wherein the processor is further configured to combine different counts of the number of cells or other entities, as the number of cells or other entities visible in the droplet changes, to determine the estimated number of cells or other entities in the droplet for the droplet sorting and/or dispensing system” The prior art of record, Kim et al, (US-PGPUB 20190384963), and Hirata et al, (US-PGPUB 2018/0193559), cited above with respect to claim 4, apply also to claim 7, but none, either alone or in combination, teach or suggest all the claimed limitations. Regarding claim 11, claim 11 recites substantially similar limitations as set forth in claim 1. As such, claim 11 is in condition of allowance, for at least similar reasons, as stated above. Regarding claim 11, claim 11 recites substantially similar limitations as set forth in claim 1. As such, claim 11 is in condition of allowance, for at least similar reasons, as stated above. Regarding claim 12, claim 12 recites substantially similar limitations as set forth in claim 5. As such, claim 12 is in condition of allowance, for at least similar reasons, as stated above. Regarding claim 13, claim 13 is in condition of allowance, in view of its dependency on claim 12. Regarding claim 14, claim 14 recites substantially similar limitations as set forth in claim 7. As such, claim 14 is in condition of allowance, for at least similar reasons, as stated above. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to AMARA ABDI whose telephone number is (571)272-0273. The examiner can normally be reached 9:00am-5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Vu Le can be reached at (571) 272-7332. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AMARA ABDI/Primary Examiner, Art Unit 2668 10/15/2026
Read full office action

Prosecution Timeline

Nov 04, 2024
Application Filed
Oct 19, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12776144
METHOD AND SYSTEM FOR CUSTOMIZED DETECTION TRACKING AND COUNTING OF PEOPLE
2y 6m to grant Granted Oct 27, 2026
Patent 12770261
Systems and Methods for Recognizing Children Suffering Cows' Milk Allergy
3y 5m to grant Granted Oct 20, 2026
Patent 12755542
ARTIFICIAL INTELLIGENCE ENABLED DISTANCE EVENT DETECTION USING IMAGE ANALYSIS
2y 11m to grant Granted Oct 06, 2026
Patent 12749345
MONITORING AND ANALYZING BODY LANGUAGE WITH MACHINE LEARNING, USING ARTIFICIAL INTELLIGENCE SYSTEMS FOR IMPROVING INTERACTION BETWEEN HUMANS, AND HUMANS AND ROBOTS
2y 7m to grant Granted Sep 29, 2026
Patent 12749346
FINGER ENCODING BASED POSE CLASSIFICATION
2y 6m to grant Granted Sep 29, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
83%
Grant Probability
76%
With Interview (-7.3%)
2y 7m (~7m remaining)
Median Time to Grant
Low
PTA Risk
Based on 846 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month